Vaccines of the future: from rational design to clinical development

Venue: Institut Pasteur

Location: Paris, France

Event Date/Time: Oct 17, 2001 End Date/Time: Oct 19, 2001
Early Registration Date: Sep 17, 2001
Abstract Submission Date: Aug 20, 2001
Report as Spam

Description

VACCINES OF THE FUTURE:
from rational design to clinical development
Institut Pasteur, Paris, France
October 17-19, 2001

Scientific Committee: C. Leclerc, P. Moingeon
Programme Director : B. B. Vargaftig

On Wednesday October 17, 2001 from 4:30 p.m.
OPENING LECTURE
A . Lanzavecchia (CH):Generation of effector and memory T cells

Thursday October 18, 2001

FROM FUNDAMENTAL RESEARCH TO RATIONAL VACCINE DESIGN: ANTIGEN IDENTIFICATION AND DELIVERY

• R. Rappuoli (I): Reverse vaccinology • M. R. Alderson (USA): Use of T-cell expression cloning to identify vaccine targets for intracellular pathogens • E. L. Reinherz (USA): Fundamentals of immune recognition: implications for manipulating the T cell repertoire • P. Ricciardi-Castagnoli (I): Targeting dendritic cells: a rational approach for vaccine development • B. Rocha (F): The cellular basis of T cell memory • C. Leclerc (F): Rational design of new vectors • D. M. Klinman (USA): CpG adjuvant activity • G. M. Glenn (USA): Transcutaneous immunization: an emerging route of immunization and potent strategy for immunostimulation • H. S. Mason (USA): Clinical trials with edible plant vaccines: present status and future challenges

Friday October 19 , 2001

FROM RATIONAL DESIGN TO CLINICAL DEVELOPMENT

• S. Cole (F): Comparative genomics as a tool for tuberculosis vaccine design • B. Gicquel (F): Rational attenuation of Mycobacterium tuberculosis. Application for vaccine design • C. L. Silva (BR): Therapeutic vaccination against tuberculosis • C.A. Siegrist (CH): Neonatal vaccinology: adressing the challenge • A.V.S. Hill (UK): Immunisation against malaria and other intra-cellular pathogens: new challenges and opportunities • C. J. M. Melief (NL): CD4+ and dendritic cells requirements for optimal CD8+ CTL induction against tumors • T. Boon (B): Therapeutic vaccination with tumor antigens recognized by cytolytic T lymphocytes • M. Klein (F): Rationale for the development of HIV therapeutic vaccines • J. D. Cohen (B): Malaria vaccine development: a status report

Round table: CHALLENGES AND OPPORTUNITIES FOR VACCINE DEVELOPMENT
Chairman: P. Moingeon (F)
•J. Almond (F) • F. Andre (B) • P. Kourilsky (F) • J.L. Romet-Lemonne (F) - CONCLUDING REMARKS: P. Kourilsky (F)

Posters and exhibitors are welcome.

For further information, please contact :
INSTITUT PASTEUR EUROCONFERENCES - 28, rue du Dr Roux - 75724 Paris Cedex 15 - France
or Fax : 33 (0)1 40 61 34 05, or e-mail : euroconf@pasteur.fr
Website: http://www.pasteur.fr/applications/euroconf/

Venue

28 rue du Dr Roux
Paris
France
MORE INFO ON THIS VENUE

Types